52 Results
Sort By:
Published on June 20, 2024
The American Society for Radiation Oncology (ASTRO) has issued new guidelines for head and neck cancer radiation therapy (RT) for the treatment of HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) that provides optimal dosing regimens either alone or after surgery aimed at minimizing doses to areas that may affect a patient’s…
Published on April 17, 2024
A study led by University of Maryland researchers has identified genetic mutations associated with persistent human papillomavirus (HPV) infection that could help identify women at risk for cervical cancer. “We found certain genetic variants were associated with having high-risk HPV infections, while other variants and human leukocyte antigen (HLA) genes…
Published on November 8, 2023
Changes in the diversity of human papillomavirus (HPV) types following vaccination may affect future cervical cancer screening programs, suggests data from a study of different vaccination strategies among communities in Finland. The study’s lead author, Ville Pimenoff, from the Karolinska Institutet in Stockholm and Oulu University in Finland, told Inside…
Published on May 17, 2023
Offering an at-home human papillomavirus (HPV) self-collection test plus appointment-scheduling assistance could double the uptake of cervical cancer screening among under-screened women from low-income backgrounds compared with scheduling assistance alone, suggest results of the US-based My Body, My Test-3 trial. Self-testing for oncogenic HPV subtypes is already used in national…
Published on March 20, 2023
Sponsored content brought to you by. In February 2023, Seegene met with Dr. Marta del Pino at Eurogin, the leading international conference focused on human papilloma virus (HPV) and associated cancers, to discuss the value of HPV testing and genotyping in the new cervical cancer screening paradigm. Read on to…
Published on January 12, 2023
The American Cancer Society (ACS) released today their annual report on cancer facts and trends, Cancer Statistics, 2023, showing overall cancer mortality has declined by 33% in the last 30 years, which translates to roughly 3.8 million deaths that were averted. The report also estimates that in the coming year,…
Published on June 17, 2022
Sponsored content brought to you by Cervical cancer is caused almost exclusively by the human papilloma virus (HPV) and has a large mortality burden, especially in the developing world. HPV has a 7.9 kb genome and replicates in the nucleus as a circular, extrachromosomal element, termed an episome, by hijacking…
Published on March 3, 2022
Researchers from The University of Texas Health Science Center are calling for targeted public health interventions to reduce growing disparities in the rates of human papillomavirus (HPV)-associated cancers among people living in disadvantaged areas. Their findings, published in JNCI Cancer Spectrum, showed that the incidence of anal and vulval cancers…
Published on December 2, 2021
Researchers at Mass Eye and Ear and Massachusetts General Hospital have developed a liquid biopsy test for head and neck cancer associated with the human papilloma virus (HPV). In a new study, the test was shown to be more accurate, faster, and cheaper than conventional testing methods. Their report, published…
Published on September 28, 2021
The current methods for diagnosing human papilloma virus are if a person has visible symptoms on their skin, or if a person have an abnormal cervical smear result. This may all change in the future, as researchers with the Margaret Cancer Center report in Clinical Cancer Research that they have…
Published on March 27, 2020
A team of scientists, led by investigators at the Albert Einstein College of Medicine just published new findings suggesting that Gardnerella bacteria in the cervicovaginal microbiome may serve as a biomarker to identify women infected with human papillomavirus (HPV), who are at risk for progression to precancer. The findings—published recently in PLOS Pathogens through…
Published on June 5, 2024
Researchers at Sweden’s Karolinska Institute and colleagues at the University of Innsbruck, Austria say they have a developed new screening method for cervical cancer that is both simpler and more effective than the current method used today. Their findings, published this week in Nature Medicine, show that that the new…
Published on May 1, 2024
Cancer screening rates are significantly lower at Federally Qualified Health Centers (FQHCs) compared to overall national rates, according to a study published in JAMA Internal Medicine. The study found screening use in FQHCs was 45.4 percent for breast cancer, 51 percent for cervical cancer and 40.2 percent for colorectal cancer,…
Published on April 1, 2024
The use of liquid biopsies, particularly as a non-invasive diagnostic tool to detect cancer, has accelerated over the past ten years. While its applications in pathologies such as lung cancer or as a tool for detecting minimal residual disease (MRD) are well-documented, researchers continue to broaden its use in hard-to-detect…
Published on December 6, 2023
Monitoring even early abnormal cells (lesions) on the cervix rather than removing them straight away increases long term risk of cancer, suggests a recent study from Denmark. While the absolute risk of cervical cancer remains low with surveillance, this approach is associated with a nearly fourfold higher risk of the…